Dermata Therapeutics, Inc.

Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System

Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025

Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing

Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office

Dermata Therapeutics Announces Closing of up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules